More on ADGM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.61 |
|
|||
| Open | $0.61 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.66 | ||||
| Day Low | $0.56 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 100,920 | ||||
- Lucid Capital Markets Starts Adagio Medical Holdings (ADGM) at Buy, PT $3, 'Underserved $5.8B Market Only 6% Penetrated'
- Adagio Medical submits FDA application for heart arrhythmia device
- Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia
- Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress
- Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference
- Adagio Medical reports positive pivotal trial results for heart device
- Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System
- Adagio Medical’s ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference
- Piper Sandler Starts Adagio Medical Holdings (ADGM) at Overweight
- Adagio Medical gets FDA approval to expand ventricular ablation trial
Entities mentioned with ADGM
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- SPAC | View Related Stories »
- Piper Jaffray | View Related Stories »
- Show More...
